Age and COPD emerged as key predictors of adverse outcomes, which is consistent with prior studies showing that older adults have heightened endothelial dysfunction and prothrombotic risk [28] and COPD patients face greater vulnerability due to reduced pulmonary reserve and increased ACE2 expression [29]. The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.